Depreciation of vTv Therapeutics Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
vTv Therapeutics Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • vTv Therapeutics Inc. Depreciation for the quarter ending 31 Mar 2025 was $9,000, a 59% decline year-over-year.
  • vTv Therapeutics Inc. annual Depreciation for 2025 was $16,000, a 82% decline from 2024.
  • vTv Therapeutics Inc. annual Depreciation for 2024 was $89,000, a 1.1% decline from 2023.
  • vTv Therapeutics Inc. annual Depreciation for 2023 was $90,000, a 2.2% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

vTv Therapeutics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $16,000 -$73,000 -82% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $89,000 -$1,000 -1.1% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $90,000 -$2,000 -2.2% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2026 2025 FY
2022 $92,000 +$3,000 +3.4% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2025 2024 FY
2021 $89,000 -$5,000 -5.3% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2020 $94,000 +$55,000 +141% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
2019 $39,000 -$179,000 -82% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022 2021 FY
2018 $218,000 +$21,000 +11% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $197,000 -$68,000 -26% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $265,000 -$236,000 -47% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $501,000 -$363,000 -42% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $864,000 -$222,000 -20% 01 Jan 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
2013 $1,086,000 01 Jan 2013 31 Dec 2013 10-K 04 Mar 2016 2015 FY

vTv Therapeutics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $9,000 -$13,000 -59% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $22,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $22,000 -$1,000 -4.3% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $23,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $23,000 -$4,000 -15% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $27,000 +$19,000 +238% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $8,000 -$34,000 -81% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $42,000 -$10,000 -19% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $52,000 -$27,000 -34% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $79,000 -$54,000 -41% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $133,000 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.